Total Funding
44
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
461668
CMC Biologics A/S provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture
Paul Tsang: Executive Vice President, Global QualityPast Role: CMC Biologics, Senior Vice President of Quality
About the Company
CMC Biologics A/S provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. The company also
provides consultancy in facility design, quality, and regulatory issues; technology evaluation; and analytical development and quality control services. CMC Biologics A/S was formerly known as CMC Biopharmaceuticals A/S. The company was incorporated in 2001 and is headquartered in Copenhagen, Denmark with additional offices in the United States and the United Kingdom.
